About the MIDD

The Milwaukee Institute for Drug Discovery (MIDD) was established to advance research and later-stage development of new drugs from research at the UW-Milwaukee and collaborating institutions. The Institute focuses on several areas of research strength at UWM, with initiatives in neuroscience, cancer, inflammation, and infectious diseases. Because of the cross-functional nature of drug discovery and development, the MIDD is focused on collaborations among UWM departments, regional and national academic centers, and medical product companies.

MIDD Mission Statement

1. establish an inter-departmental and inter-institutional program in therapeutics to advance research and later-stage development of new drugs from research at the UW-Milwaukee and collaborating institutions.
2. support collaborations among UWM departments, regional and national academic centers, and medical product companies, and coordinate efforts to maintain a robust interdisciplinary program including seeking joint funding sources and enriching the learning environment of the University and its partner institutions.
3. serve the wider community in Wisconsin by providing training and research opportunities that nurture future scholars and benefit the health of all people in the State of Wisconsin, including supporting new start-up companies that contribute to economic development in the State.